Ruth Alon
Director/Board Member at ALPHA TAU MEDICAL LTD.
Net worth: - $ as of 29/04/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Avi Elbaz | M | - |
330 Avenue Medical Health PC
330 Avenue Medical Health PC Medical SpecialtiesHealth Technology 330 Avenue Medical Health PC develops, manufactures, and distributes orthopedics and sports medicines. The firm offers treatments include knee pain (osteoarthritis, patello-femoral, meniscal tear, and ligament tear), lower back pain, hip pain (osteoarthritis), and ankle problems (post fractures and recurrent ankle sprain). The company was founded by Avi Elbaz and Amith Mor in 2004 and is headquartered in New York, NY.
APOS Medical Israel Ltd.
APOS Medical Israel Ltd. Medical/Nursing ServicesHealth Services APOS Medical Israel Ltd. is a holding company that provides non-surgical medical treatment services for musculoskeletal disorders. It offers AposTherapy, a non-surgical and drug-free medical program for knee and back pain, which utilizes an individually calibrated, foot-worn biomechanical device. The firm's program treats body's mal-alignment, muscle weakness, impaired neuromuscular control, and the resulted abnormal pathological movement patterns of orthopaedic conditions. The company was founded by Avi Elbaz and Amit Mor in 2004 and is headquartered in Herzliya Pituach, Israel. | 20 years |
Amit Mor | M | - |
330 Avenue Medical Health PC
330 Avenue Medical Health PC Medical SpecialtiesHealth Technology 330 Avenue Medical Health PC develops, manufactures, and distributes orthopedics and sports medicines. The firm offers treatments include knee pain (osteoarthritis, patello-femoral, meniscal tear, and ligament tear), lower back pain, hip pain (osteoarthritis), and ankle problems (post fractures and recurrent ankle sprain). The company was founded by Avi Elbaz and Amith Mor in 2004 and is headquartered in New York, NY.
APOS Medical Israel Ltd.
APOS Medical Israel Ltd. Medical/Nursing ServicesHealth Services APOS Medical Israel Ltd. is a holding company that provides non-surgical medical treatment services for musculoskeletal disorders. It offers AposTherapy, a non-surgical and drug-free medical program for knee and back pain, which utilizes an individually calibrated, foot-worn biomechanical device. The firm's program treats body's mal-alignment, muscle weakness, impaired neuromuscular control, and the resulted abnormal pathological movement patterns of orthopaedic conditions. The company was founded by Avi Elbaz and Amit Mor in 2004 and is headquartered in Herzliya Pituach, Israel. | 20 years |
Ilan Levin | M | 57 | 4 years | |
Yossi Gross | M | 77 |
BrainsGate Ltd.
BrainsGate Ltd. Medical SpecialtiesHealth Technology BrainsGate Ltd. develops medical devices. The firm specializes in therapies for patients suffering from central nervous system diseases. Its platform technology involves electrical stimulation of the Spheno-Palatine Ganglion, a nervous center known to increase cerebral blood flow. The company was founded by Yossi Gross and David Yarnitsky in 2000 and is headquartered in Caesarea, Israel.
TransPharma Medical Ltd.
TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities. | 24 years |
Uzi Sofer | M | 55 | 9 years | |
Peter Melnyk | M | 62 | 4 years | |
David Lorne Levy | M | 69 |
330 Avenue Medical Health PC
330 Avenue Medical Health PC Medical SpecialtiesHealth Technology 330 Avenue Medical Health PC develops, manufactures, and distributes orthopedics and sports medicines. The firm offers treatments include knee pain (osteoarthritis, patello-femoral, meniscal tear, and ligament tear), lower back pain, hip pain (osteoarthritis), and ankle problems (post fractures and recurrent ankle sprain). The company was founded by Avi Elbaz and Amith Mor in 2004 and is headquartered in New York, NY. | - |
David Suh | M | - |
Pitango Venture Capital
Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel. | 8 years |
Avinoam Dayan | M | - |
BrainsGate Ltd.
BrainsGate Ltd. Medical SpecialtiesHealth Technology BrainsGate Ltd. develops medical devices. The firm specializes in therapies for patients suffering from central nervous system diseases. Its platform technology involves electrical stimulation of the Spheno-Palatine Ganglion, a nervous center known to increase cerebral blood flow. The company was founded by Yossi Gross and David Yarnitsky in 2000 and is headquartered in Caesarea, Israel. | - |
Gabor Illés | M | - |
Treos Bio Ltd.
Treos Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Treos Bio Ltd. engages in the development of a digital cancer vaccine technology platform that provides tailored precision vaccines to patients. It focuses on cancer immunotherapies. The company was founded by john Kenneth Hautman and Julianna Lisziewicz in 2013 and is headquartered in London, the United Kingdom. | 11 years |
Itzhak Kelson | M | 84 | 9 years | |
Samuel Blumenfeld | M | 86 | 8 years | |
Yona Keisari | M | 76 | 9 years | |
John Kenneth Hautman | M | - |
Treos Bio Ltd.
Treos Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Treos Bio Ltd. engages in the development of a digital cancer vaccine technology platform that provides tailored precision vaccines to patients. It focuses on cancer immunotherapies. The company was founded by john Kenneth Hautman and Julianna Lisziewicz in 2013 and is headquartered in London, the United Kingdom. | 11 years |
Michael Basch | M | - | - | |
Clifford Bleustein | M | 53 |
APOS Medical Israel Ltd.
APOS Medical Israel Ltd. Medical/Nursing ServicesHealth Services APOS Medical Israel Ltd. is a holding company that provides non-surgical medical treatment services for musculoskeletal disorders. It offers AposTherapy, a non-surgical and drug-free medical program for knee and back pain, which utilizes an individually calibrated, foot-worn biomechanical device. The firm's program treats body's mal-alignment, muscle weakness, impaired neuromuscular control, and the resulted abnormal pathological movement patterns of orthopaedic conditions. The company was founded by Avi Elbaz and Amit Mor in 2004 and is headquartered in Herzliya Pituach, Israel. | 5 years |
Craig Marshak | M | 64 | 3 years | |
David Milch | M | 68 | 2 years | |
Ofira Kadmor | F | - |
Pitango Venture Capital
Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel. | 8 years |
David Israeli | M | - |
Pitango Venture Capital
Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel.
APOS Medical Israel Ltd.
APOS Medical Israel Ltd. Medical/Nursing ServicesHealth Services APOS Medical Israel Ltd. is a holding company that provides non-surgical medical treatment services for musculoskeletal disorders. It offers AposTherapy, a non-surgical and drug-free medical program for knee and back pain, which utilizes an individually calibrated, foot-worn biomechanical device. The firm's program treats body's mal-alignment, muscle weakness, impaired neuromuscular control, and the resulted abnormal pathological movement patterns of orthopaedic conditions. The company was founded by Avi Elbaz and Amit Mor in 2004 and is headquartered in Herzliya Pituach, Israel. | 8 years |
Srulik Dvorsky | M | - |
BrainsGate Ltd.
BrainsGate Ltd. Medical SpecialtiesHealth Technology BrainsGate Ltd. develops medical devices. The firm specializes in therapies for patients suffering from central nervous system diseases. Its platform technology involves electrical stimulation of the Spheno-Palatine Ganglion, a nervous center known to increase cerebral blood flow. The company was founded by Yossi Gross and David Yarnitsky in 2000 and is headquartered in Caesarea, Israel. | - |
Mordechay Beyar | M | - |
CarboFix Orthopedics Ltd.
CarboFix Orthopedics Ltd. Electronic Equipment/InstrumentsElectronic Technology CarboFix Orthopedics Ltd. engages in the development, manufacture, and marketing of solutions for trauma and spine. Its products include CarboClear cervical plate, CarboClear pedicle screw, proximal humerus plate, CarboClear lumbar cage, and distal fibula plate. The company was founded Mordechay Beyar in 2011 and is headquartered in Herzliya, Israel. | 13 years |
Eniko R. Toke | M | - |
Treos Bio Ltd.
Treos Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Treos Bio Ltd. engages in the development of a digital cancer vaccine technology platform that provides tailored precision vaccines to patients. It focuses on cancer immunotherapies. The company was founded by john Kenneth Hautman and Julianna Lisziewicz in 2013 and is headquartered in London, the United Kingdom. | 7 years |
Alan Adler | M | 57 | 6 years | |
Michael Avruch | M | 53 | 8 years | |
Olivier Samuel | M | 49 | 4 years | |
Doron Pinhas Birger | M | 73 | 4 years | |
Meir Jakobsohn | M | 54 | 8 years | |
Michael Tolub | M | - | 7 years | |
Eric Brachfeld | M | - | 3 years | |
Ron Abraham Mayron | M | 59 | 4 years | |
Zeev Binman | M | 70 |
Pitango Venture Capital
Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel. | 26 years |
Ofer Magen | M | - | 8 years | |
Michael Gordon | M | - |
BlueTree Technologies Ltd.
BlueTree Technologies Ltd. Beverages: Non-AlcoholicConsumer Non-Durables BlueTree Technologies Ltd. is a foodtech company based in Kiryat Shmona, Israel. BlueTree's proprietary technology and system physically and selectively reduces sugar content (up to 50%%) from 100%% squeezed natural orange juice, making it natural, healthy, and tasty. The Israeli company's technology and system offer several significant benefits to the natural juice industry, including reduced sugar, improved blending properties, and improved reduced storage and distribution. BlueTree is the first "graduate" of the FreshStart Food Tech Incubator, partnered by Tnuva, Tempo, OurCrowd, and Finistere Ventures, and is one of the leading players in the thriving northern food tech ecosystem. The company was founded by Yuval Klein and Didier Toubia, and Michael Gordon has been the CEO of the company since 2022. | 2 years |
Sharon Erde | F | - |
Pitango Venture Capital
Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel. | 17 years |
Idit Muallem | F | - |
Pitango Venture Capital
Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel. | 11 years |
James Cochran | M | - |
CarboFix Orthopedics Ltd.
CarboFix Orthopedics Ltd. Electronic Equipment/InstrumentsElectronic Technology CarboFix Orthopedics Ltd. engages in the development, manufacture, and marketing of solutions for trauma and spine. Its products include CarboClear cervical plate, CarboClear pedicle screw, proximal humerus plate, CarboClear lumbar cage, and distal fibula plate. The company was founded Mordechay Beyar in 2011 and is headquartered in Herzliya, Israel. | 8 years |
David Tanne | M | - |
BrainsGate Ltd.
BrainsGate Ltd. Medical SpecialtiesHealth Technology BrainsGate Ltd. develops medical devices. The firm specializes in therapies for patients suffering from central nervous system diseases. Its platform technology involves electrical stimulation of the Spheno-Palatine Ganglion, a nervous center known to increase cerebral blood flow. The company was founded by Yossi Gross and David Yarnitsky in 2000 and is headquartered in Caesarea, Israel. | - |
Jeffrey Saver | M | - |
BrainsGate Ltd.
BrainsGate Ltd. Medical SpecialtiesHealth Technology BrainsGate Ltd. develops medical devices. The firm specializes in therapies for patients suffering from central nervous system diseases. Its platform technology involves electrical stimulation of the Spheno-Palatine Ganglion, a nervous center known to increase cerebral blood flow. The company was founded by Yossi Gross and David Yarnitsky in 2000 and is headquartered in Caesarea, Israel. | - |
Yaniv Sagie | M | - | 6 years | |
Gil Maman | M | 41 | - | |
Asaf Shiloni | M | 54 | 3 years | |
Michael Stocker | M | - |
330 Avenue Medical Health PC
330 Avenue Medical Health PC Medical SpecialtiesHealth Technology 330 Avenue Medical Health PC develops, manufactures, and distributes orthopedics and sports medicines. The firm offers treatments include knee pain (osteoarthritis, patello-femoral, meniscal tear, and ligament tear), lower back pain, hip pain (osteoarthritis), and ankle problems (post fractures and recurrent ankle sprain). The company was founded by Avi Elbaz and Amith Mor in 2004 and is headquartered in New York, NY. | - |
Michael Shleifer | M | 49 |
Phoska Biopharma Pte Ltd.
Phoska Biopharma Pte Ltd. BiotechnologyHealth Technology Phoska Biopharma Pte Ltd. develops advancing new therapies for treating liver and metabolic conditions. The company is headquartered in Singapore. | - |
Rebecca Becker | F | - | 4 years | |
Sven Henrichwark | M | 58 |
Fibronostics US, Inc.
Fibronostics US, Inc. Packaged SoftwareTechnology Services Fibronostics US, Inc. operates healthcare technology company, which develops algorithms to detect disease and monitor progression. The firm provides platform that develops non-invasive algorithm based diagnostics to improve treatment outcomes, facilitate screening of specific diseases and help prognosis in various chronic conditions. The company was founded in 2015 and is headquartered in Orlando, FL. | 2 years |
Ronen Segal | M | 51 | 5 years | |
Amnon Gat | M | 48 | 6 years | |
Robert Den | M | 44 | 5 years | |
Raphi Levy | M | 39 | 5 years | |
Timor Arbel-Sadras | F | - |
APOS Medical Israel Ltd.
APOS Medical Israel Ltd. Medical/Nursing ServicesHealth Services APOS Medical Israel Ltd. is a holding company that provides non-surgical medical treatment services for musculoskeletal disorders. It offers AposTherapy, a non-surgical and drug-free medical program for knee and back pain, which utilizes an individually calibrated, foot-worn biomechanical device. The firm's program treats body's mal-alignment, muscle weakness, impaired neuromuscular control, and the resulted abnormal pathological movement patterns of orthopaedic conditions. The company was founded by Avi Elbaz and Amit Mor in 2004 and is headquartered in Herzliya Pituach, Israel. | - |
Michael Stocker | M | 82 |
APOS Medical Israel Ltd.
APOS Medical Israel Ltd. Medical/Nursing ServicesHealth Services APOS Medical Israel Ltd. is a holding company that provides non-surgical medical treatment services for musculoskeletal disorders. It offers AposTherapy, a non-surgical and drug-free medical program for knee and back pain, which utilizes an individually calibrated, foot-worn biomechanical device. The firm's program treats body's mal-alignment, muscle weakness, impaired neuromuscular control, and the resulted abnormal pathological movement patterns of orthopaedic conditions. The company was founded by Avi Elbaz and Amit Mor in 2004 and is headquartered in Herzliya Pituach, Israel. | 10 years |
Daniel Arthur Hallgarten | M | 63 |
Treos Bio Ltd.
Treos Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Treos Bio Ltd. engages in the development of a digital cancer vaccine technology platform that provides tailored precision vaccines to patients. It focuses on cancer immunotherapies. The company was founded by john Kenneth Hautman and Julianna Lisziewicz in 2013 and is headquartered in London, the United Kingdom. | - |
Zev Sohn | M | - |
TransPharma Medical Ltd.
TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities. | - |
Yoav Z. Chelouche | M | 70 |
APOS Medical Israel Ltd.
APOS Medical Israel Ltd. Medical/Nursing ServicesHealth Services APOS Medical Israel Ltd. is a holding company that provides non-surgical medical treatment services for musculoskeletal disorders. It offers AposTherapy, a non-surgical and drug-free medical program for knee and back pain, which utilizes an individually calibrated, foot-worn biomechanical device. The firm's program treats body's mal-alignment, muscle weakness, impaired neuromuscular control, and the resulted abnormal pathological movement patterns of orthopaedic conditions. The company was founded by Avi Elbaz and Amit Mor in 2004 and is headquartered in Herzliya Pituach, Israel. | - |
Larry Ellberger | M | 76 |
TransPharma Medical Ltd.
TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities. | - |
Rami Kalish | M | 67 |
CarboFix Orthopedics Ltd.
CarboFix Orthopedics Ltd. Electronic Equipment/InstrumentsElectronic Technology CarboFix Orthopedics Ltd. engages in the development, manufacture, and marketing of solutions for trauma and spine. Its products include CarboClear cervical plate, CarboClear pedicle screw, proximal humerus plate, CarboClear lumbar cage, and distal fibula plate. The company was founded Mordechay Beyar in 2011 and is headquartered in Herzliya, Israel. | 13 years |
Ronit Bendori | M | - |
TransPharma Medical Ltd.
TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities. | - |
Christopher C. Gallen | M | 72 |
Treos Bio Ltd.
Treos Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Treos Bio Ltd. engages in the development of a digital cancer vaccine technology platform that provides tailored precision vaccines to patients. It focuses on cancer immunotherapies. The company was founded by john Kenneth Hautman and Julianna Lisziewicz in 2013 and is headquartered in London, the United Kingdom. | - |
Giora Arbel | M | - |
TransPharma Medical Ltd.
TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities. | - |
Judith Kornfeld | F | - |
TransPharma Medical Ltd.
TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities. | - |
Bruce E. Crocker | M | - |
Pitango Venture Capital
Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel. | 24 years |
Mario Thomas | M | 73 |
TransPharma Medical Ltd.
TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities. | - |
Allen W. Hill | M | - |
BrainsGate Ltd.
BrainsGate Ltd. Medical SpecialtiesHealth Technology BrainsGate Ltd. develops medical devices. The firm specializes in therapies for patients suffering from central nervous system diseases. Its platform technology involves electrical stimulation of the Spheno-Palatine Ganglion, a nervous center known to increase cerebral blood flow. The company was founded by Yossi Gross and David Yarnitsky in 2000 and is headquartered in Caesarea, Israel. | - |
Aaron Mankovski | M | 67 |
Pitango Venture Capital
Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel. | 24 years |
Alan Milburn | M | - |
330 Avenue Medical Health PC
330 Avenue Medical Health PC Medical SpecialtiesHealth Technology 330 Avenue Medical Health PC develops, manufactures, and distributes orthopedics and sports medicines. The firm offers treatments include knee pain (osteoarthritis, patello-femoral, meniscal tear, and ligament tear), lower back pain, hip pain (osteoarthritis), and ankle problems (post fractures and recurrent ankle sprain). The company was founded by Avi Elbaz and Amith Mor in 2004 and is headquartered in New York, NY. | - |
Jason Martin | M | - |
TransPharma Medical Ltd.
TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities. | - |
Hana Gadassi | M | - |
TransPharma Medical Ltd.
TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities. | - |
Gad Huldai | M | - |
Pitango Venture Capital
Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel. | 8 years |
Ronit Nahary | F | - |
TransPharma Medical Ltd.
TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities. | - |
Zvika Slovin | M | 58 |
BrainsGate Ltd.
BrainsGate Ltd. Medical SpecialtiesHealth Technology BrainsGate Ltd. develops medical devices. The firm specializes in therapies for patients suffering from central nervous system diseases. Its platform technology involves electrical stimulation of the Spheno-Palatine Ganglion, a nervous center known to increase cerebral blood flow. The company was founded by Yossi Gross and David Yarnitsky in 2000 and is headquartered in Caesarea, Israel. | 16 years |
Christoph Wedegärtner | M | 52 |
BrainsGate Ltd.
BrainsGate Ltd. Medical SpecialtiesHealth Technology BrainsGate Ltd. develops medical devices. The firm specializes in therapies for patients suffering from central nervous system diseases. Its platform technology involves electrical stimulation of the Spheno-Palatine Ganglion, a nervous center known to increase cerebral blood flow. The company was founded by Yossi Gross and David Yarnitsky in 2000 and is headquartered in Caesarea, Israel. | - |
Noam Levy | M | - |
BrainsGate Ltd.
BrainsGate Ltd. Medical SpecialtiesHealth Technology BrainsGate Ltd. develops medical devices. The firm specializes in therapies for patients suffering from central nervous system diseases. Its platform technology involves electrical stimulation of the Spheno-Palatine Ganglion, a nervous center known to increase cerebral blood flow. The company was founded by Yossi Gross and David Yarnitsky in 2000 and is headquartered in Caesarea, Israel. | - |
Yoram Solberg | M | - |
BrainsGate Ltd.
BrainsGate Ltd. Medical SpecialtiesHealth Technology BrainsGate Ltd. develops medical devices. The firm specializes in therapies for patients suffering from central nervous system diseases. Its platform technology involves electrical stimulation of the Spheno-Palatine Ganglion, a nervous center known to increase cerebral blood flow. The company was founded by Yossi Gross and David Yarnitsky in 2000 and is headquartered in Caesarea, Israel. | - |
Isaac Hillel | M | 65 |
Pitango Venture Capital
Pitango Venture Capital Investment ManagersFinance Pitango Venture Capital (Pitango) is a venture capital firm founded in 1993 by Rami Kalish. The firm is headquartered in Herzliya, Israel. | 24 years |
Eyal Shai | M | - |
BrainsGate Ltd.
BrainsGate Ltd. Medical SpecialtiesHealth Technology BrainsGate Ltd. develops medical devices. The firm specializes in therapies for patients suffering from central nervous system diseases. Its platform technology involves electrical stimulation of the Spheno-Palatine Ganglion, a nervous center known to increase cerebral blood flow. The company was founded by Yossi Gross and David Yarnitsky in 2000 and is headquartered in Caesarea, Israel. | - |
Galit Levin | M | - |
TransPharma Medical Ltd.
TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities. | - |
Yaron Elad | M | 46 |
BrainsGate Ltd.
BrainsGate Ltd. Medical SpecialtiesHealth Technology BrainsGate Ltd. develops medical devices. The firm specializes in therapies for patients suffering from central nervous system diseases. Its platform technology involves electrical stimulation of the Spheno-Palatine Ganglion, a nervous center known to increase cerebral blood flow. The company was founded by Yossi Gross and David Yarnitsky in 2000 and is headquartered in Caesarea, Israel. | - |
Ronen Twito | M | 49 | 4 years | |
Yael Zeiger | F | 41 | 6 years | |
Denise Rivera | F | - |
APOS Medical Israel Ltd.
APOS Medical Israel Ltd. Medical/Nursing ServicesHealth Services APOS Medical Israel Ltd. is a holding company that provides non-surgical medical treatment services for musculoskeletal disorders. It offers AposTherapy, a non-surgical and drug-free medical program for knee and back pain, which utilizes an individually calibrated, foot-worn biomechanical device. The firm's program treats body's mal-alignment, muscle weakness, impaired neuromuscular control, and the resulted abnormal pathological movement patterns of orthopaedic conditions. The company was founded by Avi Elbaz and Amit Mor in 2004 and is headquartered in Herzliya Pituach, Israel. | - |
Donald V. Almeida | M | 73 |
330 Avenue Medical Health PC
330 Avenue Medical Health PC Medical SpecialtiesHealth Technology 330 Avenue Medical Health PC develops, manufactures, and distributes orthopedics and sports medicines. The firm offers treatments include knee pain (osteoarthritis, patello-femoral, meniscal tear, and ligament tear), lower back pain, hip pain (osteoarthritis), and ankle problems (post fractures and recurrent ankle sprain). The company was founded by Avi Elbaz and Amith Mor in 2004 and is headquartered in New York, NY. | - |
Peter Kadas | M | 62 |
Treos Bio Ltd.
Treos Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Treos Bio Ltd. engages in the development of a digital cancer vaccine technology platform that provides tailored precision vaccines to patients. It focuses on cancer immunotherapies. The company was founded by john Kenneth Hautman and Julianna Lisziewicz in 2013 and is headquartered in London, the United Kingdom. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Amos Ron | M | 68 | - | |
Ben Shapiro | M | 84 | 18 years | |
Dror Harats | M | 67 | 23 years | |
Marc Kozin | M | 62 | 3 years | |
Shmuel Ben Zvi | M | 64 | 5 years | |
Michael Rice | M | 59 | 2 years | |
Susan Kelley | M | 69 | 9 years | |
Rami Epstein | M | 61 | 8 years | |
Alison Finger | F | 60 | 1 years | |
David Yarnitsky | M | - |
BrainsGate Ltd.
BrainsGate Ltd. Medical SpecialtiesHealth Technology BrainsGate Ltd. develops medical devices. The firm specializes in therapies for patients suffering from central nervous system diseases. Its platform technology involves electrical stimulation of the Spheno-Palatine Ganglion, a nervous center known to increase cerebral blood flow. The company was founded by Yossi Gross and David Yarnitsky in 2000 and is headquartered in Caesarea, Israel. | - |
David Hastings | M | 62 | 5 years | |
Philip Serlin | M | 63 | - | |
Ruth Arnon | M | 90 | 14 years | |
Gary Leibler | M | 57 | 4 years | |
Scott Bullock Perper | M | - |
Kidder Peabody
| - |
Ronald Cohen | M | 68 | 7 years | |
David Sultan | M | 49 | 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
Israel | 73 | 73.00% |
United States | 23 | 23.00% |
United Kingdom | 6 | 6.00% |
Singapore | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ruth Alon
- Personal Network